Leggett Thomas
Insider CIK 1774690 · STOK Chief Financial Officer · BDTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 2,173 | $31.28 | $68.0K | 10,381 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 172 | $31.79 | $5.5K | 10,209 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-18 | 2026-03-19 | 37 | $32.85 | $1.2K | 10,172 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 1,274 | $32.74 | $41.7K | 13,476 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 922 | $33.38 | $30.8K | 12,554 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | M Exercise deriv | 2026-03-15 | 2026-03-17 | 14,750 | — | $0 | 44,250 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | M Exercise | 2026-03-15 | 2026-03-17 | 14,750 | — | $0 | 14,750 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2026-02-17 | 2026-02-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-03-20 | 2025-03-20 | 89,000 | — | $0 | 89,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2025-03-20 | 2025-03-20 | 59,000 | — | $0 | 59,000 | SEC↗ |
| STOK Stoke Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 396,200 | — | $0 | 396,200 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2021-02-17 | 2021-02-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise deriv | 2021-01-08 | 2021-01-11 | 3,000 | — | $0 | 218,171 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2021-01-08 | 2021-01-11 | 3,000 | $33.94 | $101.8K | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise | 2021-01-08 | 2021-01-11 | 3,000 | $10.86 | $32.6K | 3,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise deriv | 2020-12-08 | 2020-12-10 | 3,000 | — | $0 | 221,171 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise | 2020-12-08 | 2020-12-10 | 3,000 | $10.86 | $32.6K | 3,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2020-12-08 | 2020-12-10 | 1,941 | $34.05 | $66.1K | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2020-12-08 | 2020-12-10 | 1,059 | $33.27 | $35.2K | 1,941 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise deriv | 2020-11-09 | 2020-11-12 | 3,000 | — | $0 | 224,171 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise | 2020-11-09 | 2020-11-12 | 3,000 | $10.86 | $32.6K | 3,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2020-11-09 | 2020-11-12 | 3,000 | $32.96 | $98.9K | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise deriv | 2020-10-08 | 2020-10-09 | 3,000 | — | $0 | 227,171 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise | 2020-10-08 | 2020-10-09 | 3,000 | $10.86 | $32.6K | 3,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2020-10-08 | 2020-10-09 | 3,000 | $33.53 | $100.6K | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise deriv | 2020-09-14 | 2020-09-16 | 3,000 | — | $0 | 230,171 | SEC↗ |
| BDTX Black Diamond Therapeutics | S Sale | 2020-09-14 | 2020-09-16 | 3,000 | $31.00 | $93.0K | 0 | SEC↗ |
| BDTX Black Diamond Therapeutics | M Exercise | 2020-09-14 | 2020-09-16 | 3,000 | $10.86 | $32.6K | 3,000 | SEC↗ |
| BDTX Black Diamond Therapeutics | A Award deriv | 2020-01-29 | 2020-01-31 | 55,540 | — | $0 | 55,540 | SEC↗ |